Bradley Foster & Sargent Inc/Ct / BSX
Bradley Foster & Sargent Inc/Ct’s Boston Scientific Corp Position
Does Bradley Foster & Sargent Inc/Ct own Boston Scientific Corp (BSX)? Yes — 627.5K shares worth $39M (+0.61% of its 13F portfolio) as of Q1 2026, up from 492.9K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
627.5K
% of Portfolio
+0.61%
Quarters Held
17
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 627.5K | $39M | +0.61% |
| Q4 2025 | 492.9K | $47M | +0.69% |
| Q3 2025 | 453.9K | $44M | +0.65% |
| Q2 2025 | 554.4K | $60M | +0.93% |
| Q1 2025 | 563.1K | $57M | +0.97% |
| Q4 2024 | 578.9K | $52M | +0.87% |
| Q3 2024 | 586.2K | $49M | +0.82% |
| Q2 2024 | 668.4K | $51M | +0.93% |
| Q1 2024 | 672.6K | $46M | +0.83% |
| Q4 2023 | 675.0K | $39M | +0.76% |
| Q3 2023 | 659.3K | $36M | +0.75% |
| Q2 2023 | 659.3K | $36M | +0.75% |
| Q1 2023 | 843.2K | $42M | +1.01% |
| Q4 2022 | 838.4K | $39M | +0.97% |
| Q3 2022 | 835.9K | $32M | +0.90% |
| Q2 2022 | 830.7K | $31M | +0.80% |
| Q1 2022 | 839.2K | $37M | +0.79% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bradley Foster & Sargent Inc/Ct’s full portfolio or all institutional holders of BSX.